Table 2.
Treatments and clinical outcomes of patients by group
| HD-CRB n = 34 (100 %) | Non-HD-CRB n = 184 (100 %) | p | |
|---|---|---|---|
| Treatment (within 48 h) | |||
| Catheter removal | 27 (79.4) | 155 (84.2) | .555 |
| Vancomycin therapy | 28 (82.3) | 78 (42.4) | <.001 |
| Appropriate ATB therapya | 31 (91.2) | 118 (64.1) | .002 |
| Outcome | |||
| Persistent bacteraemia 3d | 5 (14.7) | 37 (20.1) | .463 |
| Persistent bacteraemia 7d | 2 (5.9) | 26 (14.1) | .533 |
| Complicated bacteraemia | 11 (32.4) | 89 (48.4) | .095 |
| Distant secondary focus | 5 (15.2) | 38 (20.7) | .465 |
| Endocarditis | 0 | 10 (5.4) | .368 |
| Recurrence | 3 (8.8) | 4 (2.2) | .076 |
| Early mortality (48 h) | 0 | 7 (3.8) | .599 |
| Overall mortality (30d) | 4 (11.8) | 49 (27.2) | .081 |
aATB therapy: Antibiotic therapy